Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.956
https://www.valueinhealthjournal.com/article/S1098-3015(17)31290-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
912
First Page :
A567
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31290-1&doi=10.1016/j.jval.2017.08.956